Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$23.2 - $27.29 $4.99 Million - $5.87 Million
-215,200 Reduced 13.12%
1,425,000 $35 Million
Q1 2023

May 15, 2023

BUY
$22.26 - $30.85 $17.6 Million - $24.4 Million
790,200 Added 92.96%
1,640,200 $38.2 Million
Q4 2022

Feb 14, 2023

BUY
$19.96 - $28.22 $17 Million - $24 Million
850,000 New
850,000 $21.5 Million
Q2 2022

Aug 15, 2022

SELL
$19.08 - $26.7 $415,734 - $581,766
-21,789 Reduced 2.79%
758,211 $19.3 Million
Q1 2022

May 16, 2022

BUY
$21.19 - $40.01 $1.7 Million - $3.2 Million
80,000 Added 11.43%
780,000 $20.1 Million
Q4 2021

Feb 14, 2022

BUY
$30.97 - $54.03 $5.73 Million - $10 Million
185,000 Added 35.92%
700,000 $29.3 Million
Q3 2021

Nov 15, 2021

BUY
$34.9 - $54.54 $12.3 Million - $19.3 Million
353,000 Added 217.9%
515,000 $22.4 Million
Q2 2021

Aug 16, 2021

BUY
$38.75 - $51.0 $6.28 Million - $8.26 Million
162,000 New
162,000 $7.66 Million
Q3 2020

Nov 16, 2020

SELL
$28.28 - $53.6 $17.6 Million - $33.3 Million
-620,600 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$27.89 - $47.86 $17.3 Million - $29.7 Million
620,600 New
620,600 $25.4 Million

Others Institutions Holding VIR

About Vir Biotechnology, Inc.


  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $982M
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Avidity Partners Management LP Portfolio

Follow Avidity Partners Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Avidity Partners Management LP with notifications on news.